Why is the Renergen (ASX:RLT) share price up today?

The Renergen CDI (ASX: RLT) share price is trading up this morning, after the company published two releases this morning.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Renergen CDI (ASX: RLT) share price is up this morning after the company published two releases this morning. First up, the helium and LNG producer made a trading statement this morning. The announcement acknowledges an expected reduction in loss per share for the current financial year.  Secondly, the company also published its quarterly activities and cashflow reports. This report included an update on its new vaccine transportation product.

The Renergen share price reached a high of $2.65 this morning, up 5% from its closing price yesterday. It has since dropped to $2.62 — still a 4% gain.

Let's look closer at this morning's news from Renergen.

Shareholder's delight

The company announced this morning that this financial year's loss per share and headline loss per share is expected to be significantly less than last financial year's.

Additionally, Renergen stated the loss per share and headline loss per share for the current financial year is expected to be between 27.89 cents and 37.47 cents. This represents a decrease in loss of between 21.8% and 41.8%.

The loss per share and headline loss per share for the half-year ending on 28 February 2020 was 47.92 cents.

Renergen said the previous financial year's loss per share and headline loss per share included one-off costs from debt and equity funding for the company's IPO on the ASX. 


Renergen also began its quarterly activities report by declaring its Cryo-Vacc is currently awaiting clinical validation, with results due in a matter of days.

Cryo-Vacc enables vaccines to be transported at extremely low temperatures for up to 30 days without any power supply. Powered by hydrogen, it's lightweight and can transport 100 vaccine doses at temperatures of between -70°C and -150°C.  

Cryo-Vacc was only conceptualised in December 2020. Renergen is hoping to receive clinical validation will be granted and the product will be ready when South Africa's COVID-19 vaccination tender is announced.

The company has partnered with DPD Laser locally, which is using Cryo-Vacc to support its customers participating in the tender.

Renergen Quarterly activities and cashflow report

The company also published its quarterly activities report, within which it spoke of its successful helium mining activities.

Many of the company's mining activities have achieved their expected results or performed better than anticipated. Though, some of the company's activities have been affected by logics delays caused by COVID-19 lockdowns.

Renergen share price snapshot

The Renergen share price is having a fantastic year on the ASX. Currently, it is up by 138.5% year to date. It's also up by 142.9% over the last 12 months.

The company has a market capitalisation of around  $43.5 million, with approximately 117 million shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Alumina, Kogan, Mayne Pharma, and Suncorp shares are racing higher

These ASX shares are having a strong session on Monday.

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX had a very pleasant end to the trading week this Friday.

Read more »

A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
Share Gainers

The Brainchip share price is up 213% this month. Is Nvidia to blame?

The small cap Aussie tech stock is going bananas in 2024.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Aussie Broadband, Australian Ethical, Jumbo, and Vulcan are racing higher

These ASX shares are ending the week on a high. But why?

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Share Gainers

Why Bega Cheese, Domino's, Lovisa, and Universal Store shares are rocketing today

These ASX shares are catching the eye on Thursday. But why?

Read more »

A smiling man at a shop counter takes payment from a female customer, with racks of plants in the background.
Share Gainers

The Wesfarmers share price is rising again. Should I buy the stock now?

The conglomerate reported warmly received results last week and announced a large dividend.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Share Gainers

If you'd put $20,000 in this ASX healthcare stock during COVID-19, you'd have $257,000 now

You could have become filthy rich in just 4 years. Just think about that.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Codan, Domino's, Lottery Corp, and Wisetech shares are storming higher today

These ASX shares are avoiding the market weakness today. But why?

Read more »